Elevance Health (ELV) Liabilities and Shareholders Equity (2009 - 2026)

Elevance Health (ELV) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $126.4 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 3.69% year-over-year to $126.4 billion; the TTM figure through Jun 2026 stood at $496.5 billion (up 4.51% YoY), while the FY2025 annual figure was $121.5 billion, up 3.94% from the prior year.
• Liabilities and Shareholders Equity held at $126.4 billion in Q2 2026 per ELV's latest filing, from $125.8 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $126.4 billion in Q2 2026 and bottomed at -$17.0 million in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $107.7 billion across 5 years, with a median of $112.4 billion in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slumped 325.0% — and 2023, when it jumped 640852.94%.
• Elevance Health's Liabilities and Shareholders Equity stood at -$17.0 million in 2022, then surged by 640852.94% to $108.9 billion in 2023, then grew by 7.31% to $116.9 billion in 2024, then increased by 3.94% to $121.5 billion in 2025, then climbed by 4.07% to $126.4 billion in 2026.
• Business Quant data shows ELV's Liabilities and Shareholders Equity at $126.4 billion in Q2 2026, $125.8 billion in Q1 2026, and $121.5 billion in Q4 2025.